Story excerpt provided by Crain’s Cleveland Business.
Juventas Therapeutics, a clinical-stage company developing regenerative therapies for treatment of cardiovascular disease, is bulking up its management ranks. The company said it has hired Troy Ignelzi as senior vice president of finance and operations. Ignelzi has worked for 20 years in finance, operations and business development with startup and established life sciences companies, according to a Juventas news release.
Click here to read the complete article.
Originally published October 28, 2014.